JP2019531722A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019531722A5 JP2019531722A5 JP2019515306A JP2019515306A JP2019531722A5 JP 2019531722 A5 JP2019531722 A5 JP 2019531722A5 JP 2019515306 A JP2019515306 A JP 2019515306A JP 2019515306 A JP2019515306 A JP 2019515306A JP 2019531722 A5 JP2019531722 A5 JP 2019531722A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- antigen
- virus
- stimulating
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662395438P | 2016-09-16 | 2016-09-16 | |
| US62/395,438 | 2016-09-16 | ||
| PCT/US2017/051284 WO2018052947A1 (en) | 2016-09-16 | 2017-09-13 | Platform for activation and expansion of virus-specific t-cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019531722A JP2019531722A (ja) | 2019-11-07 |
| JP2019531722A5 true JP2019531722A5 (https=) | 2020-10-01 |
| JP7002769B2 JP7002769B2 (ja) | 2022-02-04 |
Family
ID=61619728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019515306A Active JP7002769B2 (ja) | 2016-09-16 | 2017-09-13 | ウイルス特異的ｔ細胞の活性化および拡大のためのプラットフォーム |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20190194619A1 (https=) |
| EP (1) | EP3512531A4 (https=) |
| JP (1) | JP7002769B2 (https=) |
| KR (1) | KR102501827B1 (https=) |
| CN (1) | CN110177558B (https=) |
| AU (1) | AU2017326173B2 (https=) |
| CA (1) | CA3036966A1 (https=) |
| NZ (1) | NZ751571A (https=) |
| TW (1) | TWI780069B (https=) |
| WO (1) | WO2018052947A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102625832A (zh) | 2009-08-24 | 2012-08-01 | 贝勒医学院 | 产生对多种肿瘤抗原或多种病毒特异的ctl细胞系 |
| GB201121308D0 (en) | 2011-12-12 | 2012-01-25 | Cell Medica Ltd | Process |
| ES2748652T3 (es) | 2012-02-09 | 2020-03-17 | Baylor College Medicine | Mezclas pep para generar CTL multivíricos con amplia especificidad |
| EP3350600A4 (en) | 2015-09-18 | 2019-04-17 | Baylor College of Medicine | DISTINCTION OF AN IMMUNOGENIC ANTIGEN OF A PATHOGEN AND CORRELATION WITH CLINICAL EFFECTIVENESS |
| US9642906B2 (en) | 2016-09-16 | 2017-05-09 | Baylor College Of Medicine | Generation of HPV-specific T-cells |
| ES2973548T3 (es) | 2016-12-22 | 2024-06-20 | Cue Biopharma Inc | Polipéptidos multiméricos moduladores de linfocitos T y métodos para su uso |
| WO2019202118A1 (en) * | 2018-04-20 | 2019-10-24 | Baylor College Of Medicine | Oncolytic virotherapy and immunotherapy |
| CN108841792A (zh) * | 2018-06-14 | 2018-11-20 | 浙江大学 | 靶向cd19和ebna1基因修饰的t细胞及其制备方法与应用 |
| US20210301255A1 (en) * | 2018-09-10 | 2021-09-30 | Atara Biotherapeutics, Inc. | Methods for expanding antigen-specific car-t cells, compositions and uses related thereto |
| US10772914B1 (en) * | 2019-04-18 | 2020-09-15 | Baylor College Of Medicine | EBV-specific immune cells |
| WO2022056285A1 (en) * | 2020-09-10 | 2022-03-17 | Children's National Medical Center | Cytokine cocktails for selective expansion of t cell subsets |
| WO2021081232A1 (en) * | 2019-10-23 | 2021-04-29 | Cue Biopharma, Inc. | Modified cytotoxic t cells and methods of use thereof |
| WO2021101466A1 (en) * | 2019-11-19 | 2021-05-27 | Acibadem Labmed Sağlik Hi̇zmetleri̇ A.Ş. | A method for producing multivirus specific t cells |
| EP4065157A1 (en) | 2019-11-26 | 2022-10-05 | Novartis AG | Cd19 and cd22 chimeric antigen receptors and uses thereof |
| WO2021221927A1 (en) | 2020-04-27 | 2021-11-04 | Parsons Corporation | Narrowband iq signal obfuscation |
| WO2021231376A2 (en) | 2020-05-12 | 2021-11-18 | Cue Biopharma, Inc. | Multimeric t-cell modulatory polypeptides and methods of use thereof |
| KR102770127B1 (ko) * | 2020-10-28 | 2025-02-21 | 주식회사 티에스디라이프사이언스 | 이종 면역세포에 대한 화학주성을 유도하는 형질전환된 면역세포 |
| CN117529551A (zh) * | 2021-04-27 | 2024-02-06 | 贝勒医学院 | 表达嵌合抗原受体的病毒特异性免疫细胞 |
| TW202307210A (zh) | 2021-06-01 | 2023-02-16 | 瑞士商諾華公司 | Ｃｄ１９和ｃｄ２２嵌合抗原受體及其用途 |
| TW202346576A (zh) | 2022-04-13 | 2023-12-01 | 新加坡商泰莎治療有限公司 | 治療性t細胞產品 |
| EP4509137A1 (en) * | 2023-06-14 | 2025-02-19 | Kuiper, Inc. | A chimeric antigen receptor combinatorial multi-antigen targeted allogeneic t cell immunotherapy with reduced risk of t cell exhaustion, host versus graft rejection, and graft versus host disease |
| GB202318977D0 (en) * | 2023-12-12 | 2024-01-24 | Swarm Oncology Ltd | Method |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002306155A (ja) | 2001-03-27 | 2002-10-22 | Becton Dickinson & Co | 細胞を培養するための方法および装置 |
| PT1956080E (pt) * | 2005-08-08 | 2011-12-30 | San Raffaele Centro Fond | Uso de il-7 e il-15 para a modificação genética de linfócitos t da memória |
| SI2856876T1 (en) * | 2007-03-30 | 2018-04-30 | Memorial Sloan-Kettering Cancer Center | Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes |
| EP2065462A1 (en) * | 2007-11-27 | 2009-06-03 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Ex vivo method for producing a preparation containing CD4+ T cells specific for EBV structural antigens |
| WO2010119307A1 (en) * | 2009-04-14 | 2010-10-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for stimulating antigen-specific t cell responses using accelerated co-cultured dendritic cells |
| CN102625832A (zh) * | 2009-08-24 | 2012-08-01 | 贝勒医学院 | 产生对多种肿瘤抗原或多种病毒特异的ctl细胞系 |
| PH12012502233A1 (en) * | 2010-04-13 | 2022-10-05 | Immunovative Therapies Ltd | Methods and compositions for inhibition of treg cells |
| KR101749195B1 (ko) * | 2011-12-12 | 2017-06-20 | 셀 메디카 리미티드 | T 세포들을 증식시키는 방법 |
| ES2748652T3 (es) * | 2012-02-09 | 2020-03-17 | Baylor College Medicine | Mezclas pep para generar CTL multivíricos con amplia especificidad |
| KR101545217B1 (ko) * | 2012-10-29 | 2015-08-18 | 연세대학교 산학협력단 | 줄기세포의 미분화 배양 및 분화 증진을 위한 폴리도파민-펩타이드 고정화 표면 기질 및 그 제조 방법 |
| CN105335280A (zh) * | 2014-07-16 | 2016-02-17 | 北京奇虎科技有限公司 | 程序性能测试方法和装置 |
| BR112017005631A2 (pt) | 2014-09-19 | 2018-06-26 | City Of Hope | células t com receptor de antígeno coestimulador quimérico direcionadas à il13ra2 |
| JP2018510652A (ja) * | 2015-03-18 | 2018-04-19 | ベイラー カレッジ オブ メディスンＢａｙｌｏｒ Ｃｏｌｌｅｇｅ Ｏｆ Ｍｅｄｉｃｉｎｅ | Ｈｅｒ２／ｅｒｂｂ２キメラ抗原受容体 |
| US12478670B2 (en) * | 2015-03-20 | 2025-11-25 | Children's National Medical Center | Generating HPV antigen-specific T cells from a naïve T cell population |
| NZ736675A (en) * | 2015-05-12 | 2023-03-31 | Memorial Sloan Kettering Cancer Center | Methods of treating epstein-barr virus-associated lymphoproliferative disorders by t cell therapy |
| AU2016274633B2 (en) * | 2015-06-09 | 2022-04-21 | Gammadelta Therapeutics Ltd | Methods for the production of TCR gamma delta+ T cells |
| IL263924B2 (en) * | 2016-06-27 | 2025-03-01 | Yeda Res & Dev | Voto cells produced from memory T cells |
-
2017
- 2017-09-13 JP JP2019515306A patent/JP7002769B2/ja active Active
- 2017-09-13 WO PCT/US2017/051284 patent/WO2018052947A1/en not_active Ceased
- 2017-09-13 NZ NZ751571A patent/NZ751571A/en unknown
- 2017-09-13 EP EP17851424.6A patent/EP3512531A4/en active Pending
- 2017-09-13 KR KR1020197010798A patent/KR102501827B1/ko active Active
- 2017-09-13 CN CN201780066129.4A patent/CN110177558B/zh active Active
- 2017-09-13 US US16/331,494 patent/US20190194619A1/en not_active Abandoned
- 2017-09-13 AU AU2017326173A patent/AU2017326173B2/en active Active
- 2017-09-13 CA CA3036966A patent/CA3036966A1/en active Pending
- 2017-09-15 TW TW106131831A patent/TWI780069B/zh active
-
2022
- 2022-04-28 US US17/661,060 patent/US20220251509A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019531722A5 (https=) | ||
| JP7002769B2 (ja) | ウイルス特異的ｔ細胞の活性化および拡大のためのプラットフォーム | |
| US10000736B2 (en) | Method for priming of T cells | |
| Heim et al. | Heterogeneity of HBV-specific CD8+ T-cell failure: implications for immunotherapy | |
| Rydyznski et al. | Boosting vaccine efficacy the natural (killer) way | |
| JP6866988B2 (ja) | 誘導された樹状細胞およびその使用 | |
| BR112016028644B1 (pt) | Método in vitro ou ex vivo para fabricar células t, composição compreendendo um agente de crioproteção e uma população de células efetoras imunes e usos terapêuticos dadita composição | |
| CN101258238B (zh) | 抗原呈递细胞的活化处理方法 | |
| US20180305666A1 (en) | Methods for generating engineered human primary blood dendritic cell lines | |
| JP2019520823A5 (https=) | ||
| Fousteri et al. | The elusive identity of CXCR5+ CD8 T cells in viral infection and autoimmunity: Cytotoxic, regulatory, or helper cells? | |
| US20040219168A1 (en) | Method for generating highly active human dendritic cells from monocytes | |
| Ulrich-Lewis et al. | STING is required in conventional dendritic cells for DNA vaccine induction of type IT helper cell-dependent antibody responses | |
| JP6903866B2 (ja) | 血液由来単球の増殖誘導方法 | |
| CN108289913A (zh) | 从未致敏t细胞群体产生hpv抗原特异性t细胞 | |
| Buonaguro et al. | Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders | |
| King et al. | A Whole Recombinant Yeast-Based Therapeutic Vaccine Elicits HBV X | |
| Memory | Is There Natural Killer Cell Memory and Can It Be Harnessed by Vaccination? | |
| CN121195060A (zh) | 源自多能干细胞的cd4阳性t细胞、其制造方法以及其用途 | |
| Chung et al. | of June 9, 2020. | |
| Belkaid et al. | Regulation of antimicrobial immunity | |
| Quinn | Memory CD8+ T cells remain functional throughout an ongoing persistent infection: Implications for antigen-specific immune reconstitution and boosting | |
| Suttmann et al. | Vaccination/Immunotherapy | |
| Kim | The role of CD40 in dendritic cell induced CD8+ T cell responses | |
| Huang | Mechanisms underlying tumor resistance to CD8+ T cell-based therapeutic vaccination |